Showing results (1111-1120 of 2,331) with videos related to

Sort By:
Pageof 234
Clinical Drug Investigation|January 11, 2025
The Cost-Effectiveness of CDK4/6 Inhibitors in Treating HR+/HER2- Metastatic Breast Cancer Patients in the USA: When Non-medication Expenses are ConsideredAsal Pilehvari, Wen You, Gretchen Kimmick, et al.
Clinical Drug Investigation|November 25, 2023
Clinical and Laboratory Factors Related to Seizure and Serotonin Toxicity in Tramadol Intoxication: An Egyptian StudyAhmed Amin Ali, Mahmoud Mohamed Abdeshafy, Khaled Abdelkawy, et al.
Clinical Drug Investigation|March 20, 2024
Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE)Xi Tan, Victoria Divino, James Amamoo, et al.
Clinical Drug Investigation|March 9, 2024
Should Glucokinase be Given a Chance in Diabetes Therapeutics? A Clinical-Pharmacological Review of Dorzagliatin and Lessons Learned So FarUpinder Kaur, Bhairav Kumar Pathak, Tharik Jalal Meerashahib, et al.
Clinical Drug Investigation|September 21, 2024
Comparative Cost-Effectiveness of Atezolizumab Versus Durvalumab as First-Line Combination Treatment with Chemotherapy for Patients with Extensive-Disease Small-Cell Lung Cancer in JapanMunenobu Kashiwa, Miho Tsukada, Ryo Matsushita
Clinical Drug Investigation|February 23, 2024
An Open-Label Study to Assess Monthly Risperidone Injections (180 mg) Following Switch from Daily Oral Risperidone (6 mg) in Stable Schizophrenic PatientsDavid P Walling, Sunita N Shinde, Janice M Pogoda, et al.
Clinical Drug Investigation|February 16, 2024
Safety of Intravenous Push Valproate Compared with Intravenous Piggyback at a Tertiary Academic Medical CenterFelicia Y Wang, Kevin C McLaughlin, Michael J Schontz, et al.
Clinical Drug Investigation|November 16, 2023
Tauro-Urso-Deoxycholic Acid Trials in Amyotrophic Lateral Sclerosis: What is Achieved and What to ExpectMaria Lo Giudice, Antoniangela Cocco, Giorgio Reggiardo, et al.
Clinical Drug Investigation|November 7, 2023
Efficacy and Safety of Switching from Sitagliptin to Ipragliflozin in Obese Japanese Patients with Type 2 Diabetes Mellitus: A Single-Arm Multicenter Interventional StudyKentaro Watanabe, Susumu Yamaguchi, Yoshinori Kosakai, et al.
Clinical Drug Investigation|July 17, 2023
Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with OsteoarthritisMark T Brown, David R Cornblath, Martin Koltzenburg, et al.
Pageof 234